Freeport-McMoRan Inc vs 22nd Century Group Inc — how do they compare? Freeport-McMoRan Inc trades at $57.67 (market cap $87.65B), while 22nd Century Group Inc trades at $4.27 (market cap $1.52M). The key difference: Freeport-McMoRan Inc is far larger — about 57664.5× 22nd Century Group Inc's market cap, and Freeport-McMoRan Inc pays a 0.98% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals.
| FCX | XXII | |
|---|---|---|
Market Cap | $87.65B | $1.52M |
Sector | Basic Materials | Technology |
52-Week High | $71.73 | $1.47K |
52-Week Low | $35.34 | $3.90 |
Enterprise Value | $94.31B | -$6.71M |
Dividend Yield | 0.98% | — |
Signals from Pluang's Aura AI — not financial advice
FCX trades at $58.30, down 5.92% over 24 hours, with a neutral technical signal and bearish moving averages. The stock has consistently beaten earnings estimates, with Q2 2026 expected EPS of $0.60. Revenue grew to $25.92B in 2025, with net income of $2.20B and a net margin of 10.34%. The company maintains strong cash flow from operations of $5.61B and a dividend of $0.15 per share payable in August 2026.
FCX presents a favorable outlook with robust earnings performance and analyst consensus pointing to a $72.94 price target, implying significant upside. However, risks include commodity price volatility, high capital expenditures, and debt levels. The stock's current valuation at a P/E of 32.26 may limit near-term gains if growth moderates.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Freeport-McMoRan Inc is an international mining company. It operates geographically diverse assets with proven and probable mineral reserves of copper, gold and molybdenum. The company's portfolio of assets includes the Grasberg minerals district in Indonesia
Read more on FCX →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →